Method for treating inflammation and pain
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
1. A method of treating inflammation or pain, comprising the steps of:
identifying a subject suffering from inflammation or pain, and
administering to the subject a compound of 3-(methylsulfonyl)propionamide, or its pharmaceutically acceptable salt thereof, in an amount effective to treat inflammation or pain.
2. The method according to claim 1 , wherein said method reduces or alleviates the symptoms of localized manifestations of inflammation characterized by acute or chronic swelling, pain, or redness.
3. The method according to claim 1 , wherein said compound is administered topically.
4. The method according to claim 1 , wherein said compound is administered orally.
5. The method according to claim 1 , wherein said compound is administered in a pharmaceutical composition comprising a pharmaceutically acceptable carrier.
6. The method according to claim 1 , wherein said inflammation and/or pain is associated with a skeletal or muscular disease or condition selected from the group consisting of: musculoskeletal sprains, musculoskeletal strains, tendonopathy, peripheral radiculopathy, osteoarthritis, degenerative joint disease, juvenile arthritis, gout, ankylosing spondylitis, psoriatic arthritis, system lupus erythematosus, costochondritis, tendonitis, bursitis, temporomandibular joint syndrome, and fibromyalgia.
7. The method according to claim 1 , wherein said inflammation and/or pain is associated with joints, ligaments, tendons, bone, muscles, or fascia.
8. The method according to claim 1 , wherein said inflammation and/or pain is associated with dermatitis or psoriasis.
9. The method according to claim 7 , wherein said dermatitis is atopic dermatitis or contact dermatitis.